Ringworm Treatment Global Market Report 2025

The ringworm treatment market size has grown strongly in recent years. It will grow from $11.5 billion in 2024 to $12.17 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth during the historic period can be attributed to the increasing prevalence of fungal infections, greater awareness of hygiene and personal care, the growing availability of over-the-counter antifungal medications, the rising adoption of topical antifungal treatments, and the increasing incidence of immunocompromised conditions.

The ringworm treatment market size is expected to see strong growth in the next few years. It will grow to $15.14 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to the increasing demand for combination therapies, the rising prevalence of diabetes and other immunosuppressive conditions, the expansion of telemedicine for dermatological treatments, growing research on novel antifungal compounds, and the rising consumer preference for natural and herbal antifungal products. Major trends include the development of nanotechnology-based antifungal treatments, the increasing use of artificial intelligence in fungal infection diagnosis, the rising demand for prescription-based antifungal therapies, the expansion of direct-to-consumer antifungal brands, and the growing integration of antifungal treatments in skincare products.

The increasing prevalence of fungal infections is expected to drive the growth of the ringworm treatment market. Fungal infections occur when fungi overgrow or invade the body, affecting various organs and tissues. The rise in these infections is attributed to factors such as increased use of immunosuppressive treatments, global warming, and a growing population with compromised immune systems. Ringworm treatment plays a crucial role in managing fungal infections by providing effective antifungal therapies that prevent spread, reduce complications, and control infection rates, particularly in vulnerable populations. For instance, in November 2024, the UK Health Security Agency (UKHSA), a UK-based government agency, reported a 4% rise in bloodstream infections caused by yeast in England in 2022 compared to the previous year, highlighting an upward trend in fungal-related health issues. Additionally, in September 2024, the International Society for Infectious Diseases, a US-based nonprofit organization, estimated that invasive fungal infections occur at an annual rate of 6.5 million cases globally, leading to approximately 3.8 million deaths, with 2.5 million directly attributed to these infections. Over 2.1 million people develop invasive aspergillosis each year. As a result, the increasing incidence of fungal infections is fueling the expansion of the ringworm treatment market.

The advancement of healthcare facilities is also expected to contribute to the growth of the ringworm treatment market. Healthcare facilities, including hospitals, clinics, and diagnostic centers, provide essential medical services for diagnosing and treating various conditions. Improvements in healthcare infrastructure, a focus on patient-centered care, population growth, and an aging demographic have driven enhancements in these facilities. The availability of ringworm treatment has supported healthcare improvements by fostering specialized dermatological care, increasing patient education on fungal infections, and promoting the adoption of accessible, effective treatment options. These efforts help healthcare systems expand their ability to manage skin-related diseases more efficiently, leading to improved public health outcomes. For example, in May 2023, the American Health Care Association, a US-based nonprofit organization, reported that the number of hospitals in the United States increased from 6,093 in the previous year to 6,129, reflecting a 0.591% growth. This improvement in healthcare infrastructure is further driving the expansion of the ringworm treatment market.

Companies in the ringworm treatment market are focusing on developing innovative solutions, such as full-cycle skin infection control formulations, to enhance treatment effectiveness and prevent recurrence. A full-cycle skin infection control formulation is designed to target all stages of a skin infection, from eliminating the pathogen to preventing recurrence, soothing inflammation, and promoting skin healing. For instance, in May 2022, Bayer AG, a Germany-based pharmaceutical company, launched an improved version of Canesten, an antifungal brand. The updated Canesten product line features an advanced formulation designed to provide faster relief from fungal infections while being gentle on the skin. The relaunch emphasizes a full-cycle treatment approach by combining antifungal, anti-inflammatory, and skin-soothing properties in a single product, ensuring not only effective infection control but also long-term prevention of recurrence. These innovations are shaping the future of the ringworm treatment market by providing more comprehensive and patient-friendly solutions.

Major players in the ringworm treatment market are Pfizer Inc., Merck & Co. Inc., Bayer Healthcare, Sanofi-Aventis, Abbott Laboratories, Novartis AG, GlaxoSmithKline Plc (GSK), Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Aurobindo Pharma Ltd., Dr Reddy's Laboratories Ltd., Cipla Ltd., Intas Pharmaceuticals Ltd., Zydus Group, Glenmark Pharmaceuticals Inc., Biocon Limited, Torrent Pharmaceuticals Ltd., Taro Pharmaceutical Industries Ltd., Enzon Pharmaceuticals.

North America was the largest region in the ringworm treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in ringworm treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the ringworm treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Ringworm treatment involves the use of medications to eliminate the fungal infection caused by dermatophytes, relieve symptoms such as itching and redness, and prevent the spread of the contagious condition to other body areas or individuals. Along with medication, maintaining proper hygiene, keeping affected areas dry, and avoiding direct contact with infected individuals or surfaces help manage and prevent the recurrence of ringworm infections.

The primary drug classes for ringworm treatment include antifungals and combination drugs. Antifungals are designed to prevent, control, or eliminate fungal infections by targeting fungal cells while minimizing harm to the host. Treatment options address various types of ringworm, such as tinea corporis, tinea pedis, tinea cruris, tinea capitis, and tinea manuum, with administration routes including topical, oral, and parenteral. These treatments are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

The ringworm treatment market research report is one of a series of new reports that provides ringworm treatment market statistics, including ringworm treatment industry global market size, regional shares, competitors with a ringworm treatment market share, detailed ringworm treatment market segments, market trends and opportunities, and any further data you may need to thrive in the ringworm treatment industry. This ringworm treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ringworm treatment market consists of sales of adjunctive treatment, azoles, and allylamines. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.